Dr. Rachel Pozzar, PhD

Claim this profile
Studies Ovarian Cancer
Studies Ovarian Tumors
1 reported clinical trial
1 drug studied

Area of expertise

1Ovarian Cancer
Rachel Pozzar, PhD has run 1 trial for Ovarian Cancer. Some of their research focus areas include:
Stage III
Stage IV
2Ovarian Tumors
Rachel Pozzar, PhD has run 1 trial for Ovarian Tumors. Some of their research focus areas include:
Stage III
Stage IV

Clinical Trials Rachel Pozzar, PhD is currently running

More about Rachel Pozzar, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Rachel Pozzar, PhD has experience with
  • Collaborative Agenda-Setting Intervention
Breakdown of trials Rachel Pozzar, PhD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Pozzar, PhD specialize in?
Rachel Pozzar, PhD focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage IV.
Is Rachel Pozzar, PhD currently recruiting for clinical trials?
Yes, Rachel Pozzar, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Rachel Pozzar, PhD has studied deeply?
Yes, Rachel Pozzar, PhD has studied treatments such as Collaborative Agenda-Setting Intervention.
What is the best way to schedule an appointment with Rachel Pozzar, PhD?
Apply for one of the trials that Rachel Pozzar, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.